Keros Therapeutics Inc (KROS) — institutional ownership

142 funds reported holding Keros Therapeutics Inc in their latest 13F filings, worth $233M in total (CUSIP 492327101).

Largest holders

1. VANGUARD GROUP INC — $31.1M
2. BlackRock, Inc. (BLK) — $29.9M
3. Nantahala Capital Management, LLC — $15.1M
4. AQR CAPITAL MANAGEMENT LLC — $10.4M
5. VANGUARD CAPITAL MANAGEMENT LLC — $8.92M
6. ORBIMED ADVISORS LLC — $8.12M
7. FEDERATED HERMES, INC. (FHI) — $7.49M
8. VANGUARD PORTFOLIO MANAGEMENT LLC — $6.98M
9. MACKENZIE FINANCIAL CORP — $6.72M
10. Madison Avenue Partners, LP — $6.70M

Famous investors holding it

• Ken Griffin portfolio (Citadel Advisors)
• Renaissance Technologies portfolio (Renaissance Technologies)
• D. E. Shaw portfolio (D. E. Shaw & Co.)
• Two Sigma portfolio (Two Sigma Investments)
• Izzy Englander portfolio (Millennium Management)

Insider buying and selling at Keros Therapeutics Inc

Who owns the most KROS stock?

The largest institutional holders in the latest 13F filings are VANGUARD GROUP INC ($31.1M), BlackRock, Inc. (BLK) ($29.9M), Nantahala Capital Management, LLC ($15.1M).

How many funds own KROS?

142 funds reported holding it, worth $233M in total.